OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Ocugen, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.79+0.01 (+0.90%)
Close on Oct 19, 2026
- Market cap
- $266.64M
- P/E (TTM)
- –
- Dividend yield
- –
Ocugen statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Ocugen | Industry median |
|---|---|---|
| Market Cap | $266.98M | $166.30M |
| Enterprise Value | $168.68M | $88.19M |
Income (trailing twelve months)
| Measure | Ocugen | Industry median |
|---|---|---|
| Operating Income | -$68.90M | -$21.40M |
| Net Income | -$81.81M | -$22.46M |
| EBITDA | -$68.90M | -$16.91M |
Returns
| Measure | Ocugen | Industry median |
|---|---|---|
| Return on Assets (ROA) | -92.0% | -40.9% |
Growth
| Measure | Ocugen | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | 21.0% | 2.25% |
| Revenue Growth (5Y CAGR) | 152.5% | 6.48% |
Balance sheet
| Measure | Ocugen | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $100.05M | $61.43M |
| Total Debt | $1.75M | $118.52M |
| Net Cash (Debt) | $98.30M | $15.35M |
| Net Cash Per Share | $0.29 | $0.66 |
| Equity (Book Value) | -$16.56M | $49.09M |
| Book Value Per Share | -$0.05 | $1.37 |
| Tangible Book Value | -$16.56M | $23.52M |
| Working Capital | -$26.36M | $76.81M |
Financial position
| Measure | Ocugen | Industry median |
|---|---|---|
| Current Ratio | 0.80 | 3.34 |
| Quick Ratio | 0.75 | 2.44 |
| Interest Coverage | -8.16 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Ocugen | Industry median |
|---|---|---|
| Operating Cash Flow | -$60.87M | -$12.35M |
| Capital Expenditures | -$153.00K | -$1.08M |
| Free Cash Flow | -$61.02M | -$20.22M |
| FCF Per Share | -$0.18 | -$0.42 |
Efficiency
| Measure | Ocugen | Industry median |
|---|---|---|
| Profits Per Employee | -$705.27K | -$703.34K |
| Employee Count | 116 | 74 |
Dividends and yields
| Measure | Ocugen | Industry median |
|---|---|---|
| Earnings Yield | -30.6% | -23.3% |
| FCF Yield | -22.9% | -8.72% |
Shares
| Measure | Ocugen | Industry median |
|---|---|---|
| Shares Outstanding | 339,110,000 | 58,127,000 |
| Shares Change (QoQ) | 0.21% | 0.54% |
| Float | 330,414,000 | 49,136,700 |
| Shares Held by Insiders | 2.56% | 11.6% |
| Shares Held by Institutions | 42.8% | 59.4% |
Scores
| Measure | Ocugen | Industry median |
|---|---|---|
| Altman Z-Score | -6.04 | -0.22 |
| Piotroski F-Score | 0 | 4 |
Calculated by StockData from Ocugen's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.